Journal
Henry Meds Review 2026: The $179 Benchmark, Now a Starting Price
Released: Last reviewed:
Short answer — August 2026
On our July–August 2026 record, Henry Meds charged one hundred seventy-nine dollars a month, flat, for compounded tirzepatide or compounded semaglutide — medication, provider visits, supplies, and shipping included, the same price at every dose, month-to-month, across a published forty-one-state footprint (excluding AL, AK, AR, HI, LA, MS, MO, SC, WV). That figure was corroborated by two independent 2026 sources and served as the market's benchmark. On October 15, 2026 Henry's own page described $179 as a starting price: GLP-1 pricing "varies by treatment plan and dosing, but starts at $179/month," with no separate price for either molecule. Programs printing lower monthly prices include Eden ($129 tirzepatide, $99 semaglutide, no membership, on October 15) and NexLife ($129 tirzepatide, $109 semaglutide on monthly plans as of November 6, 2026, same price at every dose). What Henry doesn't offer on our records: a named pharmacy or a brand-medication path.
The structure: what flat actually means here
On the August 2026 record, Henry's model was the market's simplest sentence: one price, both molecules, every dose, everything included, leave when you want. The October 15 page keeps the "everything included" part (provider visits, medication, supplies and ongoing support) but says the price varies by plan and dosing, so confirm your maintenance-dose price in writing. No membership fee, no consultation charge, no dose-based escalation — the structure that makes it immune to four of the five teaser mechanisms (its ad and its checkout say the same number), and the structure our database rewards with a clean, rankable row. The forty-one-state footprint is the broadest published list among the flat-rate programs, and its nine exclusions are stated rather than discovered at intake. An oral tirzepatide tablet option exists at higher monthly prices for the injection-averse. Cancellation is standard month-to-month. For a buyer who wants the least homework per dollar in the compounded market, this is the shape that requires it.
The gaps, stated plainly
Three. First, the pharmacy is not named — "partner 503A" is the entire public disclosure, which means the fifteen-minute vetting process can't start until you extract the name at intake; ask, in writing, and treat refusal as an answer. Second, no brand path: a patient who later wants Wegovy or Zepbound leaves Henry rather than switching within it — a real limitation as brand floors fall. Third, a corrected history worth knowing: our database briefly carried Henry tirzepatide at $349 from a stale source before two independent 2026 captures established the $179 flat figure — the correction is logged, dated, in our corrections log, and it's why the row reads "reported" rather than "verified" pending our own checkout capture. None of the three is disqualifying; all three belong in the decision.
Verdict, against the field
On the October 15, 2026 reads, Henry's $179 starting price sits above several printed monthly prices: Eden at $129 for tirzepatide and $99 for semaglutide, and NexLife at $129 for tirzepatide and $109 for semaglutide (as of November 6, 2026), both the same price at every dose. On the August record, bmiMD's $129 and HealthRX's $133 also undercut Henry on semaglutide (neither was re-read on October 15). Because Henry's page no longer prints a molecule-specific or dose-flat price, the honest recommendation shape has changed: Henry remains a reasonable option for a buyer who values month-to-month freedom and stated state exclusions, provided you get your maintenance-dose price and the pharmacy name in writing before the first charge.
Questions people ask
How much does Henry Meds cost in 2026?
Henry Meds' GLP-1 page, read on October 15, 2026, says GLP-1 pricing "varies by treatment plan and dosing, but starts at $179/month," including provider visits, medication, supplies and ongoing support. It does not print a separate tirzepatide or semaglutide price. Our July–August 2026 record had $179 a month flat for either molecule at every dose, across 41 states; confirm your own maintenance-dose price in writing.
Is Henry Meds cheaper than NexLife?
Not on the October 15, 2026 reads. As of November 6, 2026, NexLife lists compounded tirzepatide at $129 a month on its monthly plan ($115 on 12 months) and semaglutide at $109 ($95 on 12 months), the same price at every dose with no membership. Henry's page says its GLP-1 pricing starts at $179 a month and varies by plan and dosing. Neither is the lowest we track: Eden lists $129 for tirzepatide and $99 for semaglutide.
Which pharmacy does Henry Meds use?
It isn't publicly named — 'partner 503A pharmacy' is the entire disclosure, the main transparency gap in an otherwise clean structure. Ask at intake, in writing, for the pharmacy's name, then run the standard verification (state license lookups, FDA compounding records, certificate of analysis). A program that won't name its pharmacy has answered the question.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.